375 related articles for article (PubMed ID: 31706167)
1. Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation.
Gmuca S; Hardy DI; Narula S; Stoll S; Harris J; Zhao Y; Xiao R; Weiss PF; Waldman AT; Gerber JS
Mult Scler Relat Disord; 2020 Jan; 37():101488. PubMed ID: 31706167
[TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.
Mealy MA; Wingerchuk DM; Greenberg BM; Levy M
Arch Neurol; 2012 Sep; 69(9):1176-80. PubMed ID: 22733096
[TBL] [Abstract][Full Text] [Related]
4. Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients.
Kanikannan MA; Arepareddy PK; Mathukumalli NL; Y S; Kandadai RM; Jabeen AS; T S; Borgohain R
Mult Scler Relat Disord; 2019 Oct; 35():164-169. PubMed ID: 31382202
[TBL] [Abstract][Full Text] [Related]
5. A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment.
Baghbanian SM; Asgari N; Sahraian MA; Moghadasi AN
J Neurol Sci; 2018 May; 388():222-231. PubMed ID: 29478727
[TBL] [Abstract][Full Text] [Related]
6. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
[TBL] [Abstract][Full Text] [Related]
7. Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
Dale GH; Svendsen KB; Gjelstrup MC; Christensen T; Houen G; Nielsen E; Bek T; Petersen T
Acta Neurol Scand; 2018 Jun; 137(6):582-588. PubMed ID: 29359475
[TBL] [Abstract][Full Text] [Related]
8. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
Evangelopoulos ME; Andreadou E; Koutsis G; Koutoulidis V; Anagnostouli M; Katsika P; Evangelopoulos DS; Evdokimidis I; Kilidireas C
J Neurol Sci; 2017 Jan; 372():92-96. PubMed ID: 28017256
[TBL] [Abstract][Full Text] [Related]
9. Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients.
Carnero Contentti E; Soto de Castillo I; Daccach Marques V; López PA; Antunes Barreira A; Armas E; de Aquino Cruz C; Rubstein A; Lavigne Moreira C; Molina OM; Soto A; Tkachuk V
Mult Scler Relat Disord; 2018 Feb; 20():109-114. PubMed ID: 29367170
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
11. Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.
Bennett JL
J Neuroophthalmol; 2016 Sep; 36(3):238-45. PubMed ID: 27529327
[TBL] [Abstract][Full Text] [Related]
12. Chiari malformation Type I surgery in pediatric patients. Part 1: validation of an ICD-9-CM code search algorithm.
Ladner TR; Greenberg JK; Guerrero N; Olsen MA; Shannon CN; Yarbrough CK; Piccirillo JF; Anderson RC; Feldstein NA; Wellons JC; Smyth MD; Park TS; Limbrick DD
J Neurosurg Pediatr; 2016 May; 17(5):519-24. PubMed ID: 26799412
[TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of neuromyelitis optica spectrum disorders - An update.
Bruscolini A; Sacchetti M; La Cava M; Gharbiya M; Ralli M; Lambiase A; De Virgilio A; Greco A
Autoimmun Rev; 2018 Mar; 17(3):195-200. PubMed ID: 29339316
[TBL] [Abstract][Full Text] [Related]
15. The 2015 IPND Criteria Increases the Yield in Diagnosis of Neuromyelitis Optica Spectrum Disorder in Thai Patients Compared to the 2006 Diagnostic Criteria.
Rattanathamsakul N; Kaveeta C; Siritho S; Thakolwiboon S; Prayoonwiwat N
Mult Scler Relat Disord; 2020 Aug; 43():102218. PubMed ID: 32474289
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A
Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870
[TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
Domingos J; Isidoro L; Figueiredo R; Brum M; Capela C; Barros P; Santos E; Macário Mdo C; Pinto Marques J; Pedrosa R; Vale J; Sá MJ
Clin Neurol Neurosurg; 2015 Jul; 134():79-84. PubMed ID: 25965287
[TBL] [Abstract][Full Text] [Related]
18. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Wingerchuk DM; Banwell B; Bennett JL; Cabre P; Carroll W; Chitnis T; de Seze J; Fujihara K; Greenberg B; Jacob A; Jarius S; Lana-Peixoto M; Levy M; Simon JH; Tenembaum S; Traboulsee AL; Waters P; Wellik KE; Weinshenker BG;
Neurology; 2015 Jul; 85(2):177-89. PubMed ID: 26092914
[TBL] [Abstract][Full Text] [Related]
19. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
20. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
